Glenmark Pharmaceuticals ltd — Investor Relations & Filings
Glenmark Pharmaceuticals Ltd. is a research-driven global organization focused on the development, manufacturing, and marketing of generic, specialty, and over-the-counter medicines. The company maintains a specialized focus on therapeutic areas including dermatology, respiratory health, and oncology. It operates a robust research and development pipeline featuring New Chemical Entities (NCEs) and New Biological Entities (NBEs), supported by multiple global R&D centers. Its commercial footprint extends across North America, Europe, and emerging markets. The company is distinguished by its expertise in complex generics and its integrated approach to drug discovery and formulation development. Glenmark utilizes a network of advanced manufacturing facilities to deliver high-quality healthcare solutions globally, emphasizing innovation and accessibility in its product portfolio.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Credit Rating | 2018-07-12 | English | |
| Press Release | 2018-07-06 | English | |
| Press Release | 2018-06-19 | English | |
| Press Release | 2018-06-06 | English | |
| Updates | 2018-05-29 | English | |
| Outcome of Board Meeting | 2018-05-29 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 43538220 | Credit Rating | 2018-07-12 | English | ||
| 43553659 | Press Release | 2018-07-06 | English | ||
| 43551255 | Press Release | 2018-06-19 | English | ||
| 43552562 | Press Release | 2018-06-06 | English | ||
| 43587081 | Updates | 2018-05-29 | English | ||
| 43588826 | Outcome of Board Meeting | 2018-05-29 | English | ||
| 43589748 | ESOP/ESOS/ESPS | 2018-05-29 | English | ||
| 43590746 | Dividend | 2018-05-29 | English | ||
| 43590867 | Financial Result Updates | 2018-05-29 | English | ||
| 43615819 | Press Release | 2018-05-28 | English | ||
| 43563608 | Analysts/Institutional Investor Meet/Con. Call Updates | 2018-05-23 | English | ||
| 43574656 | Press Release | 2018-05-22 | English | ||
| 43581445 | Press Release | 2018-05-21 | English | ||
| 43592273 | Press Release | 2018-05-18 | English | ||
| 43564441 | Trading Window | 2018-05-16 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Glenmark Pharmaceuticals ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62608/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62608 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62608 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62608 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62608}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Glenmark Pharmaceuticals ltd (id: 62608)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.